These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8428468)

  • 21. Naloxone and methylprednisolone sodium succinate enhance sympathomedullary discharge in patients with septic shock.
    Hughes GS
    Life Sci; 1984 Dec; 35(23):2319-26. PubMed ID: 6390057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low total cholesterol and high total bilirubin are associated with prognosis in patients with prolonged sepsis.
    Yamano S; Shimizu K; Ogura H; Hirose T; Hamasaki T; Shimazu T; Tasaki O
    J Crit Care; 2016 Feb; 31(1):36-40. PubMed ID: 26596698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.
    Cohen J; Carlet J
    Crit Care Med; 1996 Sep; 24(9):1431-40. PubMed ID: 8797612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
    Moskowitz A; Andersen LW; Cocchi MN; Karlsson M; Patel PV; Donnino MW
    Ann Am Thorac Soc; 2017 May; 14(5):737-741. PubMed ID: 28207287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
    Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.
    Opal SM; Fisher CJ; Dhainaut JF; Vincent JL; Brase R; Lowry SF; Sadoff JC; Slotman GJ; Levy H; Balk RA; Shelly MP; Pribble JP; LaBrecque JF; Lookabaugh J; Donovan H; Dubin H; Baughman R; Norman J; DeMaria E; Matzel K; Abraham E; Seneff M
    Crit Care Med; 1997 Jul; 25(7):1115-24. PubMed ID: 9233735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged low-dose dopamine infusion induces a transient improvement in renal function in hemodynamically stable, critically ill patients: a single-blind, prospective, controlled study.
    Ichai C; Passeron C; Carles M; Bouregba M; Grimaud D
    Crit Care Med; 2000 May; 28(5):1329-35. PubMed ID: 10834674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: results of a prospective randomized study.
    Schmidt SC; Hamann S; Langrehr JM; Höflich C; Mittler J; Jacob D; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2007; 14(5):484-92. PubMed ID: 17909718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.
    Bloos F; Trips E; Nierhaus A; Briegel J; Heyland DK; Jaschinski U; Moerer O; Weyland A; Marx G; Gründling M; Kluge S; Kaufmann I; Ott K; Quintel M; Jelschen F; Meybohm P; Rademacher S; Meier-Hellmann A; Utzolino S; Kaisers UX; Putensen C; Elke G; Ragaller M; Gerlach H; Ludewig K; Kiehntopf M; Bogatsch H; Engel C; Brunkhorst FM; Loeffler M; Reinhart K;
    JAMA Intern Med; 2016 Sep; 176(9):1266-76. PubMed ID: 27428731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial.
    Pickkers P; Heemskerk S; Schouten J; Laterre PF; Vincent JL; Beishuizen A; Jorens PG; Spapen H; Bulitta M; Peters WH; van der Hoeven JG
    Crit Care; 2012 Jan; 16(1):R14. PubMed ID: 22269279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnesium repletion and its effect on potassium homeostasis in critically ill adults: results of a double-blind, randomized, controlled trial.
    Hamill-Ruth RJ; McGory R
    Crit Care Med; 1996 Jan; 24(1):38-45. PubMed ID: 8565536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock.
    Luce JM; Montgomery AB; Marks JD; Turner J; Metz CA; Murray JF
    Am Rev Respir Dis; 1988 Jul; 138(1):62-8. PubMed ID: 3202402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.
    Lherm T; Troché G; Rossignol M; Bordes P; Zazzo JF
    Intensive Care Med; 1996 Mar; 22(3):213-9. PubMed ID: 8727434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemofiltrastion does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Jan; 10(1):11-7. PubMed ID: 15737948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.
    Mussack T; Briegel J; Schelling G; Biberthaler P; Jochum M
    Clin Chem Lab Med; 2005; 43(3):259-68. PubMed ID: 15843228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.
    Dhainaut JF; Tenaillon A; Le Tulzo Y; Schlemmer B; Solet JP; Wolff M; Holzapfel L; Zeni F; Dreyfuss D; Mira JP
    Crit Care Med; 1994 Nov; 22(11):1720-8. PubMed ID: 7956274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Feb; 10(2):81-7. PubMed ID: 15817428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study.
    Forceville X; Laviolle B; Annane D; Vitoux D; Bleichner G; Korach JM; Cantais E; Georges H; Soubirou JL; Combes A; Bellissant E
    Crit Care; 2007; 11(4):R73. PubMed ID: 17617901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients.
    Heemskerk S; Masereeuw R; Moesker O; Bouw MP; van der Hoeven JG; Peters WH; Russel FG; Pickkers P;
    Crit Care Med; 2009 Feb; 37(2):417-23, e1. PubMed ID: 19114895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.